Goldman Sachs’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,750
| Closed | -$6.2K | – | 6531 |
|
|
2024
Q4 | $6.2K | Hold |
14,750
| – | – | ﹤0.01% | 5943 |
|
|
2024
Q3 | $29.1K | Buy |
14,750
+45
| +0.3% | +$171 | ﹤0.01% | 5657 |
|
|
2024
Q2 | $78.5K | Buy |
+14,705
| New | +$61.4K | ﹤0.01% | 5426 |
|
|
2022
Q4 | – | Sell |
-45
| Closed | -$25K | – | 6341 |
|
|
2022
Q3 | $25K | Hold |
45
| – | – | ﹤0.01% | 5902 |
|
|
2022
Q2 | $37K | Hold |
45
| – | – | ﹤0.01% | 6088 |
|
|
2022
Q1 | $119K | Sell |
45
-327
| -88% | -$694K | ﹤0.01% | 6050 |
|
|
2021
Q4 | $960K | Sell |
372
-500
| -57% | -$1.74M | ﹤0.01% | 4880 |
|
|
2021
Q3 | $3.99M | Hold |
872
| – | – | ﹤0.01% | 3548 |
|
|
2021
Q2 | $5.19M | Hold |
872
| – | – | ﹤0.01% | 3304 |
|
|
2021
Q1 | $7.06M | Hold |
872
| – | – | ﹤0.01% | 2844 |
|
|
2020
Q4 | $5.41M | Hold |
872
| – | – | ﹤0.01% | 2946 |
|
|
2020
Q3 | $5.93M | Hold |
872
| – | – | ﹤0.01% | 2761 |
|
|
2020
Q2 | $5.54M | Hold |
872
| – | – | ﹤0.01% | 2726 |
|
|
2020
Q1 | $2.83M | Buy |
872
+7
| +0.8% | +$29.1K | ﹤0.01% | 3070 |
|
|
2019
Q4 | $5.06M | Hold |
865
| – | – | ﹤0.01% | 2952 |
|
|
2019
Q3 | $10.8M | Hold |
865
| – | – | ﹤0.01% | 2264 |
|
|
2019
Q2 | $7.26M | Buy |
865
+4
| +0.5% | +$46.9K | ﹤0.01% | 2593 |
|
|
2019
Q1 | $11.3M | Buy |
861
+3
| +0.3% | +$51K | ﹤0.01% | 2316 |
|
|
2018
Q4 | $12.9M | Hold |
858
| – | – | ﹤0.01% | 2155 |
|
|
2018
Q3 | $32M | Hold |
858
| – | – | 0.01% | 1561 |
|
|
2018
Q2 | $33.2M | Buy |
858
+2
| +0.2% | +$75.9K | 0.01% | 1526 |
|
|
2018
Q1 | $27.8M | Buy |
856
+2
| +0.2% | +$53.8K | 0.01% | 1577 |
|
|
2017
Q4 | $17.6M | Hold |
854
| – | – | ﹤0.01% | 2033 |
|
|
2017
Q3 | $17.9M | Hold |
854
| – | – | ﹤0.01% | 2081 |
|
|
2017
Q2 | $13.7M | Buy |
854
+3
| +0.4% | +$60.1K | ﹤0.01% | 2260 |
|
|
2017
Q1 | $22.4M | Hold |
851
| – | – | 0.01% | 1807 |
|
|
2016
Q4 | $22.4M | Hold |
851
| – | – | 0.01% | 1879 |
|
|
2016
Q3 | $30.8M | Hold |
851
| – | – | 0.01% | 1576 |
|
|
2016
Q2 | $33.6M | Buy |
851
+6
| +0.7% | +$271K | 0.01% | 1392 |
|
|
2016
Q1 | $41.6M | Buy |
845
+10
| +1% | +$442K | 0.01% | 1205 |
|
|
2015
Q4 | $45.7M | Buy |
835
+140
| +20% | +$7.55M | 0.01% | 1188 |
|
|
2015
Q3 | $30.4M | Hold |
695
| – | – | 0.01% | 1402 |
|
|
2015
Q2 | $56.4M | Buy |
695
+4
| +0.6% | +$347K | 0.02% | 1031 |
|
|
2015
Q1 | $53.7M | Hold |
691
| – | – | 0.02% | 1041 |
|
|
2014
Q4 | $66.5M | Hold |
691
| – | – | 0.02% | 906 |
|
|
2014
Q3 | $62.5M | Buy |
+691
| New | +$64.3M | 0.02% | 914 |
|
Goldman Sachs's TTOO Position: Q1 2025 in Review
Goldman Sachs sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 14,750 shares — an estimated $6.2K sold.
Goldman Sachs first reported a position in TTOO in Q3 2014 and held it in 36 quarters. The position peaked at $66.5M in Q4 2014. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Goldman Sachs reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Goldman Sachs sold 14,750 T2 Biosystems, Inc shares in Q1 2025, an estimated $6.2K.
- Goldman Sachs first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 36 quarters.
- Goldman Sachs's T2 Biosystems, Inc position peaked at $66.5M in Q4 2014.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.